Estados Unidos · Bolsa y Finanzas · TechCrunch

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Publicado por TechCrunch · Estados Unidos hace 1 d

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand…

Leer el artículo completo en TechCrunch Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (techcrunch.com)

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

También te puede interesar

ByteDance's short-drama app is turning into China's latest obsession

Collective Metals announces $515K non-brokered private placement

Balaji’s ‘Singapore of social media’ begins with a wave of bans

Fed's Warsh withholds Fed rate signal, praises recent global tightening with 'no free riders'

Why Bad News in the Bond Market May Be Good News for Investors

An OpenAI agent ran out of Ethereum funds, and took from a wallet it did not own

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Compartir

También te puede interesar

ByteDance's short-drama app is turning into China's latest obsession

Collective Metals announces $515K non-brokered private placement

Balaji’s ‘Singapore of social media’ begins with a wave of bans

Fed's Warsh withholds Fed rate signal, praises recent global tightening with 'no free riders'

Why Bad News in the Bond Market May Be Good News for Investors

An OpenAI agent ran out of Ethereum funds, and took from a wallet it did not own